+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antivirals"

From
Monkeypox - Competitive Landscape, 2024 - Product Thumbnail Image

Monkeypox - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Ebola Virus - Competitive Landscape, 2024 - Product Thumbnail Image

Ebola Virus - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
HSV-1 Keratitis - Competitive landscape, 2024 - Product Thumbnail Image

HSV-1 Keratitis - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
Shingles - Pipeline Insight, 2024 - Product Thumbnail Image

Shingles - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
From
Cytomegalovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Cytomegalovirus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
BK Virus (BKV) Infection - Pipeline Insight, 2024 - Product Thumbnail Image

BK Virus (BKV) Infection - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Lassa Fever - Pipeline Insight, 2024 - Product Thumbnail Image

Lassa Fever - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
West Nile - Pipeline Insight, 2024 - Product Thumbnail Image

West Nile - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2024 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 75 Pages
  • Global
From
Influenza virus B infections - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza virus B infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Dengue - Pipeline Insight, 2024 - Product Thumbnail Image

Dengue - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Influenza - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 280 Pages
  • Global
From
Genital Warts - Pipeline Insight, 2024 - Product Thumbnail Image

Genital Warts - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Hepatitis C Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis C Virus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator

The Antivirals market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat viral infections. Antivirals are used to treat a wide range of viral infections, including influenza, HIV, herpes, hepatitis, and other respiratory infections. Antivirals work by targeting the virus itself, preventing it from replicating and spreading throughout the body. They can also be used to reduce the severity of symptoms and shorten the duration of the illness. Antivirals are typically administered orally or intravenously, depending on the type of virus and the severity of the infection. In some cases, antivirals may be used in combination with other drugs to increase their effectiveness. Some of the major companies in the Antivirals market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, and Bristol-Myers Squibb. These companies produce a variety of antiviral drugs, including those used to treat influenza, HIV, herpes, and hepatitis. Show Less Read more